Last reviewed · How we verify
NCT06652516
Comparison Between Centrifugation Based and Membrane Based Plasma Exchange
NA trial testing plasma exchange in Therapeutic Plasma Exchange in 20 participants. Completed in 8 December 2023.
10 September 2023
Quick facts
| Lead sponsor | Alexandria University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 5 January 2023 |
| Primary completion | 10 September 2023 |
| Estimated completion | 8 December 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- plasma exchange — full drug profile →
Conditions studied
- Therapeutic Plasma Exchange — all drugs for Therapeutic Plasma Exchange →
Sponsor
Alexandria University
Who can join
Adults 18 to 80, any sex, with Therapeutic Plasma Exchange. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims at comparing centrifugation based therapeutic plasma exchange (cTPE) versus membrane based therapeutic plasma exchange (mTPE) as regards performance, effectiveness and adverse events in patients indicated for TPE.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Study of Centrifugal Therapeutic Plasma Exchange and Membrane Therapeutic Plasma Exchange; A Comparative Study.
Elghoneimy HA, Elkader MMA, Saad NLM, Tawfiq AA, et al · · 2026 · PMID 41422826 · DOI 10.1002/1744-9987.70104
Verify or expand the search:
- PubMed search for NCT06652516
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of plasma exchange
Trials testing the same drug.
- NCT06562803 — Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis · NA · recruiting
- NCT04949698 — Risk Factors and the Effect of Plasma Exchange on Prognosis of Pregnancy-related Thrombotic Microangiopathies · unknown
- NCT04747106 — Thromboelastography Guides a Multicentre Cluster Controlled Study of Plasma Exchange for Hepatitis B Associated Acute-on · NA · unknown
- NCT01442233 — Plasma Exchanges in Multiple Sclerosis (MS) Relapses · Phase 3 · completed
Other Alexandria University trials
Trials by the same sponsor.
- NCT07517861 — Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Clinical Readiness · NA · recruiting
- NCT07476482 — The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delive · NA · enrolling by invitation
- NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
- NCT07503626 — Optimization of Orthodontic Bracket Placement by Using Two Different Protocols of Digitally Aided Bonding · NA · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06652516 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alexandria University
- Last refreshed: 22 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06652516.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing